UBS Group’s INmune Bio INMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.04M Buy
449,221
+311,906
+227% +$721K ﹤0.01% 4332
2025
Q1
$1.07M Buy
137,315
+1,067
+0.8% +$8.33K ﹤0.01% 4151
2024
Q4
$636K Buy
136,248
+93,092
+216% +$435K ﹤0.01% 4545
2024
Q3
$233K Buy
43,156
+2,863
+7% +$15.4K ﹤0.01% 4586
2024
Q2
$355K Buy
40,293
+1,993
+5% +$17.6K ﹤0.01% 4165
2024
Q1
$450K Sell
38,300
-4,915
-11% -$57.8K ﹤0.01% 4173
2023
Q4
$487K Buy
43,215
+1,365
+3% +$15.4K ﹤0.01% 4000
2023
Q3
$283K Sell
41,850
-10,400
-20% -$70.4K ﹤0.01% 4018
2023
Q2
$474K Sell
52,250
-1,394
-3% -$12.7K ﹤0.01% 3868
2023
Q1
$347K Buy
53,644
+8,614
+19% +$55.6K ﹤0.01% 3958
2022
Q4
$285K Buy
45,030
+5,080
+13% +$32.2K ﹤0.01% 4114
2022
Q3
$248K Buy
39,950
+1,000
+3% +$6.21K ﹤0.01% 3897
2022
Q2
$344K Buy
38,950
+3,000
+8% +$26.5K ﹤0.01% 3607
2022
Q1
$303K Hold
35,950
﹤0.01% 4095
2021
Q4
$367K Buy
35,950
+5,824
+19% +$59.5K ﹤0.01% 4204
2021
Q3
$585K Buy
30,126
+22,680
+305% +$440K ﹤0.01% 3627
2021
Q2
$131K Buy
7,446
+4,137
+125% +$72.8K ﹤0.01% 4642
2021
Q1
$39K Buy
3,309
+3,059
+1,224% +$36.1K ﹤0.01% 5774
2020
Q4
$4K Buy
+250
New +$4K ﹤0.01% 6879
2020
Q3
Sell
-820
Closed -$4K 7229
2020
Q2
$4K Sell
820
-309
-27% -$1.51K ﹤0.01% 6595
2020
Q1
$4K Buy
1,129
+1,079
+2,158% +$3.82K ﹤0.01% 6468
2019
Q4
$0 Sell
50
-636
-93% ﹤0.01% 7099
2019
Q3
$4K Buy
686
+399
+139% +$2.33K ﹤0.01% 6581
2019
Q2
$2K Sell
287
-922
-76% -$6.43K ﹤0.01% 6739
2019
Q1
$9K Buy
+1,209
New +$9K ﹤0.01% 6039